World's Best Scientists 2026 revealed!
S. Vincent Rajkumar

S. Vincent Rajkumar

Award Badge
Best Scientists
2025

D-Index & Metrics

Best Scientists

D-Index
173
Citations
124701
World Ranking
772
National Ranking
471

Medicine

D-Index
173
Citations
129881
World Ranking
474
National Ranking
281

Research.com Recognitions

  • 2025 - Research.com Best Scientists Award

Overview

S. Vincent Rajkumar is affiliated with the Mayo Clinic in the United States. Their research primarily focuses on hematology, molecular biology, oncology, genetics, and pathology. Across these fields, they have contributed extensively to the study of multiple myeloma and related hematolymphoid disorders.

The main topics covered in their work include:

  • Multiple Myeloma Research and Treatments
  • Protein Degradation and Inhibitors
  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • Chronic Lymphocytic Leukemia Research
  • Peptidase Inhibition and Analysis
  • Cancer Treatment and Pharmacology
  • Myeloproliferative Neoplasms: Diagnosis and Treatment

Frequent co-authors collaborating with Rajkumar are:

  • Shaji Kumar
  • Angela Dispenzieri
  • Morie A. Gertz
  • Prashant Kapoor
  • Francis K. Buadi

Rajkumar has published prolifically in various venues, with the most frequent publication outlets listed as:

  • Blood
  • Blood Cancer Journal
  • Clinical Lymphoma Myeloma & Leukemia
  • Leukemia
  • Journal of Clinical Oncology

Notable recent papers authored or co-authored by Rajkumar include:

  • Multiple myeloma: 2022 update on diagnosis, risk stratification, and management, 2022, American Journal of Hematology
  • Multiple myeloma: 2020 update on diagnosis, risk-stratification and management, 2020, American Journal of Hematology
  • Multiple myeloma current treatment algorithms, 2020, Blood Cancer Journal
  • The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms, 2022, Leukemia
  • The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee, 2022, Blood

Their research outputs span a robust intersection of clinical hematology and molecular biology, emphasizing diagnosis, risk stratification, and therapeutic strategies for hematologic malignancies, particularly multiple myeloma.

Best Publications

  • International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.

    S. Vincent Rajkumar;Meletios A. Dimopoulos;Antonio Palumbo;Joan Blade

  • A phase 2 study of bortezomib in relapsed, refractory myeloma.

    Paul G. Richardson;Bart Barlogie;James Berenson;Seema Singhal

  • International uniform response criteria for multiple myeloma

    B. G. M. Durie;J.-L. Harousseau;J. S. Miguel;J. Blade

  • Review of 1027 Patients With Newly Diagnosed Multiple Myeloma

    Robert A. Kyle;Morie A. Gertz;Thomas E. Witzig;John A. Lust

  • Improved survival in multiple myeloma and the impact of novel therapies

    Shaji K. Kumar;S. Vincent Rajkumar;Angela Dispenzieri;Martha Q. Lacy

  • International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

    Shaji Kumar;Bruno Paiva;Kenneth C. Anderson;Brian Durie

  • Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group

    Antonio Palumbo;Hervé Avet-Loiseau;Stefania Oliva;Henk M. Lokhorst

  • A long-term study of prognosis in monoclonal gammopathy of undetermined significance.

    Robert A. Kyle;Terry M. Therneau;S. Vincent Rajkumar;Janice R. Offord

  • Initial genome sequencing and analysis of multiple myeloma

    Michael A. Chapman;Michael S. Lawrence;Jonathan J. Keats;Kristian Cibulskis

  • Prevalence of Monoclonal Gammopathy of Undetermined Significance

    Robert A. Kyle;Terry M. Therneau;S. Vincent Rajkumar;Dirk R. Larson

  • Lenalidomide plus Dexamethasone for Relapsed Multiple Myeloma in North America

    Donna M. Weber;Christine Chen;Ruben Niesvizky;Michael Wang

  • Drug therapy: Multiple myeloma

    Robert A. Kyle;S. Vincent Rajkumar

  • Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients

    S K Kumar;A Dispenzieri;M Q Lacy;M A Gertz

  • Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma

    R A Kyle;S V Rajkumar

  • Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: A prospective study

    Ola Landgren;Robert A. Kyle;Ruth M. Pfeiffer;Jerry A. Katzmann

  • Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial

    S Vincent Rajkumar;Susanna Jacobus;Natalie S Callander;Rafael Fonseca

  • Phase III Clinical Trial of Thalidomide Plus Dexamethasone Compared With Dexamethasone Alone in Newly Diagnosed Multiple Myeloma: A Clinical Trial Coordinated by the Eastern Cooperative Oncology Group

    S. Vincent Rajkumar;Emily Blood;David Vesole;Rafael Fonseca

  • Revised Prognostic Staging System for Light Chain Amyloidosis Incorporating Cardiac Biomarkers and Serum Free Light Chain Measurements

    Shaji Kumar;Angela Dispenzieri;Martha Q. Lacy;Suzanne R. Hayman

  • Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1

    S. Vincent Rajkumar;Jean Luc Harousseau;Brian Durie;Kenneth C. Anderson

  • Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma.

    Robert A. Kyle;Ellen D. Remstein;Terry M. Therneau;Angela Dispenzieri

Frequent Co-Authors

Shaji Kumar
Shaji Kumar Mayo Clinic
Morie A. Gertz
Morie A. Gertz Mayo Clinic
Robert A. Kyle
Robert A. Kyle Mayo Clinic
Martha Q. Lacy
Martha Q. Lacy Mayo Clinic
Francis K. Buadi
Francis K. Buadi Mayo Clinic
David Dingli
David Dingli Mayo Clinic
John A. Lust
John A. Lust Mayo Clinic
Nelson Leung
Nelson Leung Mayo Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re exploring a career in Medicine, there are numerous related online degree pathways that can complement or offer alternative routes into healthcare. For those seeking a transition into nursing, absn programs that don't require teas can ease entry barriers and help you become a registered nurse more efficiently.

Interested in healthcare leadership? Consider advancing rapidly with an accelerated healthcare administration degree online. This is ideal for individuals eager to move into management roles in hospitals or clinics.

Current registered nurses can also explore rn to np programs online to obtain a nurse practitioner credential and significantly expand their practice and responsibilities.

For those interested in dietetics or holistic health, an online degree in nutrition opens doors to careers in wellness, food science, and health education.

These flexible online programs support diverse medical and allied health ambitions, providing practical options for different interests and life circumstances.

Best Scientists Citing S. Vincent Rajkumar

Trending Scientists

Recently Published Articles